D'ONGHIA, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 657
EU - Europa 78
AS - Asia 55
Continente sconosciuto - Info sul continente non disponibili 3
Totale 793
Nazione #
US - Stati Uniti d'America 656
CN - Cina 49
SE - Svezia 35
IT - Italia 16
FI - Finlandia 8
GB - Regno Unito 7
BE - Belgio 5
VN - Vietnam 4
DE - Germania 2
EU - Europa 2
HK - Hong Kong 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
FR - Francia 1
IE - Irlanda 1
RO - Romania 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 793
Città #
Fairfield 120
Woodbridge 91
Houston 67
Chandler 62
Ashburn 50
Seattle 47
Cambridge 36
Nyköping 26
Ann Arbor 24
Beijing 24
Wilmington 24
Jacksonville 10
Roxbury 10
Lawrence 8
Nanjing 7
Bari 6
Brooklyn 6
Des Moines 6
Norwalk 6
Princeton 6
Brussels 5
Shenyang 5
Dong Ket 4
Inglewood 4
Redwood City 4
San Diego 4
Dearborn 3
Hebei 3
Tianjin 3
Hong Kong 2
Jesi 2
Jiaxing 2
London 2
Phoenix 2
Taranto 2
Boardman 1
Brierley Hill 1
Chengdu 1
Chicago 1
Dublin 1
Guiyang 1
Hanover 1
Hefei 1
Irvine 1
Jinan 1
Kansas City 1
Leninsk-kuznetskiy 1
Lviv 1
Marseille 1
New Bedfont 1
Quzhou 1
Santa Marinella 1
Toronto 1
Trani 1
Totale 702
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 123
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta 114
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 102
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 100
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 89
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 88
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 83
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 69
null 65
null 21
Totale 854
Categoria #
all - tutte 3.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 0 0 0 0 0 0 0 29 29
2019/2020262 29 13 5 20 25 16 24 33 29 26 35 7
2020/2021151 16 10 12 10 12 12 21 13 8 18 9 10
2021/202292 6 6 0 2 5 10 4 5 8 11 16 19
2022/2023146 22 22 8 20 13 13 0 18 21 1 3 5
2023/202424 4 7 2 5 3 1 0 2 0 0 0 0
Totale 854